John Kao Sells 355,018 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Key Points

• CEO John Kao of Alignment Healthcare sold 355,018 shares of the company's stock for approximately $5.83 million, reducing his total ownership by 7.26% to 4,533,568 shares.
• Alignment Healthcare's stock price declined by 0.2% to $16.45, with significant trading volume of 4,860,124 shares compared to its average of 2,946,361 shares.
• The company's latest quarterly earnings showed 49% revenue growth year-over-year, reporting $1.02 billion, surpassing analysts' expectations of $960.25 million.

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) CEO John Kao sold 355,018 shares of the company's stock in a transaction dated Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total transaction of $5,825,845.38. Following the completion of the sale, the chief executive officer owned 4,533,568 shares in the company, valued at approximately $74,395,850.88. This trade represents a 7.26% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Alignment Healthcare Stock Down 0.2%

Alignment Healthcare stock traded down $0.03 during midday trading on Wednesday, reaching $16.45. 4,860,124 shares of the company traded hands, compared to its average volume of 2,946,361. The business has a 50 day moving average of $14.27 and a two-hundred day moving average of $15.47. Alignment Healthcare, Inc. has a 12 month low of $8.82 and a 12 month high of $21.06. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 2.29.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.14. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The business had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $960.25 million. During the same quarter last year, the company posted ($0.13) EPS. The company's revenue was up 49.0% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ALHC. Vanguard Group Inc. grew its holdings in shares of Alignment Healthcare by 13.2% during the 1st quarter. Vanguard Group Inc. now owns 11,113,896 shares of the company's stock worth $206,941,000 after purchasing an additional 1,295,825 shares during the period. T. Rowe Price Investment Management Inc. grew its position in Alignment Healthcare by 5.0% in the first quarter. T. Rowe Price Investment Management Inc. now owns 9,078,113 shares of the company's stock worth $169,035,000 after buying an additional 429,071 shares during the last quarter. Wellington Management Group LLP lifted its position in shares of Alignment Healthcare by 0.9% in the 1st quarter. Wellington Management Group LLP now owns 7,509,057 shares of the company's stock valued at $139,819,000 after acquiring an additional 70,557 shares in the last quarter. Hood River Capital Management LLC grew its position in Alignment Healthcare by 6.0% during the second quarter. Hood River Capital Management LLC now owns 5,517,336 shares of the company's stock valued at $77,243,000 after purchasing an additional 311,424 shares in the last quarter. Finally, 8 Knots Management LLC increased its holdings in Alignment Healthcare by 6.4% in the second quarter. 8 Knots Management LLC now owns 5,015,881 shares of the company's stock worth $70,222,000 after buying an additional 300,409 shares during the last quarter. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

ALHC has been the topic of several analyst reports. Zacks Research upgraded shares of Alignment Healthcare to a "hold" rating in a report on Friday, August 8th. Wall Street Zen lowered shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, August 10th. Barclays upgraded Alignment Healthcare from an "underweight" rating to an "equal weight" rating and boosted their price target for the stock from $9.00 to $13.00 in a research note on Thursday, July 31st. Stephens raised shares of Alignment Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Finally, KeyCorp raised shares of Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 target price on the stock in a research note on Monday, August 25th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $18.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.